Overview: Understanding Alcohol Use Disorder
Alcohol use disorder (AUD) is a chronic medical condition characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. It ranges in severity from mild to severe and is diagnosed based on criteria in the DSM-5, including craving, loss of control, increasing tolerance, and withdrawal symptoms.
The scope of the problem is staggering:
- 14.5 million Americans ages 12 and older had AUD in the most recent national survey data.
- 140,000 Americans die from alcohol-related causes every year — making it the fourth-leading preventable cause of death in the United States.
- Alcohol is directly linked to liver cirrhosis, multiple cancers (mouth, throat, esophagus, liver, breast, colon), cardiovascular disease, pancreatitis, brain damage, and immune system suppression.
- Alcohol is the only commonly used recreational substance where withdrawal can be fatal. Severe alcohol withdrawal (delirium tremens) carries a mortality rate of 1 to 5% even with medical treatment.
Conventional Treatment
The standard approaches to AUD treatment include:
- Behavioral therapy — cognitive-behavioral therapy (CBT), motivational enhancement therapy, and 12-step facilitation (Alcoholics Anonymous).
- Naltrexone — an opioid antagonist that reduces the rewarding effects of alcohol. Available as a daily pill or monthly injection (Vivitrol). Reduces heavy drinking days and relapse rates.
- Acamprosate (Campral) — helps restore the brain's chemical balance disrupted by chronic alcohol use. Reduces cravings and protects against relapse.
- Disulfiram (Antabuse) — causes extremely unpleasant reactions (nausea, vomiting, flushing) when alcohol is consumed, creating an aversion-based deterrent.
- Medical detoxification — medically supervised withdrawal management, typically using benzodiazepines to prevent seizures and other life-threatening complications.
- Residential and outpatient treatment programs — structured programs that combine medical management, therapy, peer support, and life skills training.
These treatments are evidence-based and help many people achieve and maintain sobriety. However, AUD has high relapse rates — approximately 40 to 60% of people relapse within the first year of treatment — and many individuals cycle through multiple treatment attempts. This reality has prompted researchers and clinicians to explore additional tools, including cannabis.
What the Research Says
The evidence around cannabis and alcohol use disorder is moderate and growing. There are genuine signals of interest in the research, but no large-scale randomized controlled trials have definitively established cannabis as an AUD treatment.
Cannabis Substitution Studies
Multiple surveys and observational studies have found that when cannabis is available, some people voluntarily reduce their alcohol consumption:
A 2019 study published in the International Journal of Drug Policy found that 44% of medical cannabis users reported using cannabis as a substitute for alcohol. Among those who substituted, the most commonly cited reasons were fewer side effects, better symptom management, and less withdrawal potential.
Lucas et al., International Journal of Drug Policy, 2019
This substitution pattern has been replicated across multiple studies. People report choosing cannabis over alcohol for reasons including: fewer next-day effects (no hangover), reduced aggression, lower caloric intake, and the perception of less overall harm.
Population-Level Data
Looking beyond individual surveys, researchers have examined what happens at the population level when cannabis becomes legally available:
- States with medical cannabis laws have shown measurable reductions in alcohol-related traffic fatalities, suggesting that at least some portion of the population shifts consumption from alcohol to cannabis when given legal access.
- A 2023 study found that cannabis legalization was associated with a 10% reduction in alcohol sales, indicating a meaningful substitution effect at the market level.
- Research analyzing hospital admission data in states with legal cannabis found decreases in alcohol-related emergency department visits and hospitalizations.
The Harm Reduction Argument
The central argument for considering cannabis in the context of AUD is not that cannabis is harmless — it is that its harm profile is dramatically lower than alcohol's:
| Harm Category | Alcohol | Cannabis |
|---|---|---|
| Overdose deaths | ~140,000 per year (U.S.) | Zero confirmed fatal overdoses |
| Organ damage | Liver cirrhosis, brain damage, pancreatitis, cardiomyopathy | No equivalent organ destruction profile |
| Cancer risk | Directly causes at least 7 types of cancer | No established causal link to cancer |
| Fatal withdrawal | Yes — delirium tremens can be lethal | No — withdrawal is uncomfortable but not dangerous |
| Physical dependence | Severe; develops relatively quickly | Mild to moderate in some users |
| Violence association | Strongly associated with domestic violence, assaults, homicides | Generally associated with reduced aggression |
| Impaired driving risk | Dramatically increases crash risk | Increases crash risk, but to a lesser degree |
From a strict harm reduction perspective, if a person with AUD replaces some or all of their alcohol consumption with cannabis, the net health impact is likely positive — even acknowledging cannabis's own risks. This is analogous to nicotine replacement therapy for smoking: the replacement is not risk-free, but it is dramatically less harmful than the substance it replaces.
The Endocannabinoid System and Alcohol Addiction
There is a biological basis for the relationship between cannabis and alcohol use. The endocannabinoid system (ECS) plays a significant role in alcohol addiction:
- Chronic heavy alcohol use dysregulates the endocannabinoid system, altering CB1 receptor density and endocannabinoid signaling. This disruption contributes to the anxiety, irritability, and craving that drive relapse.
- CB1 receptor availability is significantly reduced in people with AUD, and these changes persist well into early sobriety, potentially contributing to protracted withdrawal symptoms.
- Preclinical (animal) studies suggest that modulating the ECS — including through cannabinoids — may reduce alcohol intake, craving, and relapse behavior.
- CBD specifically has shown promise in reducing alcohol-seeking behavior in animal models and may have neuroprotective properties against alcohol-induced brain damage.
The endocannabinoid system is significantly disrupted by chronic alcohol exposure, and preclinical evidence suggests that targeting this system — including through phytocannabinoids — may offer therapeutic potential for alcohol use disorder.
Parsons & Hurd, Neuropsychopharmacology Reviews, 2015
How People Use Cannabis for Alcohol Reduction
The following section describes patterns reported by patients and in surveys. This is observational, not clinical guidance. Anyone with AUD should work with a healthcare provider.
In surveys and patient reports, people who use cannabis to reduce alcohol consumption describe several patterns:
- Direct substitution — using cannabis in situations where they would otherwise drink (after work, social events, weekends). For some, cannabis provides the relaxation or social lubrication they previously sought from alcohol, without the hangover, calorie load, or escalating health damage.
- Craving management — using a small dose of cannabis when alcohol cravings hit, as an alternative to giving in. Some people report that cannabis reduces the intensity and urgency of alcohol cravings, providing a "circuit breaker" that helps them get through trigger moments.
- Early sobriety support — using cannabis during the first weeks or months of alcohol abstinence to manage insomnia, anxiety, irritability, and other withdrawal-adjacent symptoms that often drive relapse. This use is typically seen as a temporary bridge, not a permanent solution.
- Gradual tapering — some people report using cannabis to incrementally reduce their drinking rather than quitting abruptly. Over weeks or months, they shift the ratio of cannabis to alcohol until alcohol is eliminated or dramatically reduced.
Recommended Starting Points
These are general guidelines based on research patterns and harm reduction principles, not prescriptions. Work with a healthcare provider, ideally an addiction medicine specialist.
Cannabinoid Profiles
- Start with CBD-dominant or high-CBD products. For people concerned about substituting one intoxicant for another, CBD-dominant products (20:1 or higher CBD:THC ratio) provide potential anxiety and craving relief without significant psychoactive effects. This is a reasonable starting point, especially for people in recovery who want to avoid intoxication entirely.
- Consider 1:1 THC:CBD ratios. If some degree of psychoactive effect is desired (for example, to replace the relaxation component of alcohol), balanced products reduce the risk of THC-related anxiety while providing a more noticeable effect than CBD alone.
- Low-THC options. If THC-dominant products are preferred, start at 2.5 mg or less. The goal is to find the minimum amount that satisfies the craving or provides the desired relaxation — not to get as high as possible.
Consumption Methods
- Tinctures offer precise dosing and a moderate onset time (15 to 30 minutes), making them a good option for controlled, intentional use.
- Low-dose edibles (2.5 to 5 mg THC) provide longer-lasting effects that may cover the evening hours when alcohol cravings tend to peak.
- CBD tinctures or capsules can be used during the day for baseline anxiety management without any impairment.
Terpenes to Consider
- Myrcene — sedating and relaxing, may help replace the "winding down" sensation sought from alcohol.
- Linalool — calming properties, found in lavender, may help with the anxiety component of cravings.
- Beta-caryophyllene — interacts with CB2 receptors and has shown anti-inflammatory and anxiolytic properties in preclinical research. Found in black pepper, cloves, and some cannabis strains.
For more on dosing, see our Dosing Fundamentals page. For consumption methods, see Methods of Consumption.
Risks & Considerations
The cannabis-for-AUD conversation is nuanced, and intellectual honesty requires acknowledging serious concerns alongside potential benefits:
- Cross-addiction potential. Approximately 29% of regular cannabis users meet criteria for cannabis use disorder. People with a history of substance use disorders are at elevated risk of developing problematic relationships with any psychoactive substance, including cannabis. Replacing alcohol dependence with cannabis dependence is not the goal.
- Cannabis is not a proven treatment for AUD. Despite promising signals, no large-scale clinical trial has established cannabis or any cannabinoid as an approved treatment for alcohol use disorder. The current evidence is observational, survey-based, and population-level. It is suggestive, not conclusive.
- People with substance use histories need extra caution. If you have struggled with alcohol or other substance dependencies, your brain's reward circuitry may be more susceptible to developing dependence on cannabis. This does not mean cannabis is off the table, but it means you should use it with greater intentionality and ideally under professional guidance.
- This should be discussed with an addiction specialist. Self-medicating AUD with cannabis, without professional guidance, is not recommended. An addiction medicine physician or a counselor specializing in substance use disorders can help you develop a plan that includes appropriate monitoring, clear goals, and strategies to avoid simply trading one substance problem for another.
- AA and 12-step perspectives. Many people in recovery participate in Alcoholics Anonymous or other 12-step programs, which traditionally define sobriety as abstinence from all mind-altering substances. If cannabis substitution is part of your plan, be aware that some recovery communities may view this as inconsistent with sobriety. Programs like harm reduction-focused groups and SMART Recovery may be more compatible with this approach.
- Mental health considerations. AUD frequently co-occurs with depression, anxiety, and PTSD. Cannabis may help or hinder these conditions depending on the product, dose, and individual. Co-occurring mental health conditions should be addressed as part of any treatment plan.
- Do not combine cannabis with active heavy drinking. If you are currently drinking heavily, adding cannabis on top increases impairment, nausea, and risk. The harm reduction benefit comes from substitution, not addition.
Talk to Your Doctor
If you are considering cannabis as part of an alcohol reduction or harm reduction strategy, the most important thing you can do is talk to a healthcare provider — specifically one with experience in addiction medicine.
Who to Talk To
- Addiction medicine specialists — physicians board-certified in addiction medicine are best equipped to evaluate whether cannabis substitution makes sense for your specific situation. The American Society of Addiction Medicine (ASAM) maintains a provider directory.
- Your primary care physician — even if they are not a specialist, your PCP can assess your overall health, evaluate medication interactions, and refer you to appropriate specialists.
- Licensed addiction counselors — therapists specializing in substance use disorders can help you develop coping strategies and monitor whether cannabis use is helping or creating new problems.
What to Say
- "I am trying to reduce my drinking, and I have been reading about cannabis as a harm reduction tool. I want to discuss whether this is appropriate for me."
- "I want to be honest: I am already using cannabis to help manage my alcohol cravings. Can you help me do this more safely?"
- "I am in recovery and want to avoid relapse. Could CBD products support my sobriety without creating new dependence issues?"
SAMHSA Resources
The Substance Abuse and Mental Health Services Administration (SAMHSA) offers free, confidential resources:
- National Helpline: 1-800-662-4357 — free, confidential, 24/7 treatment referral and information service (English and Spanish)
- Treatment Locator: findtreatment.gov — searchable directory of substance use treatment facilities
For a more general guide on discussing cannabis with healthcare providers, visit our Talking to Your Doctor page.
Further Reading
Studies Referenced on This Page
- Lucas et al. (2019), International Journal of Drug Policy — Cannabis substitution for alcohol among medical cannabis users
- Parsons & Hurd (2015), Neuropsychopharmacology Reviews — Endocannabinoid system involvement in alcohol addiction
Related Pages on TryCannabis.org
- Cannabis vs. Alcohol — a comprehensive comparative harm analysis
- Responsible Recreational Use — harm reduction guide for adult recreational users
- Cannabis Use Disorder — understanding and preventing problematic cannabis use
- Drug Interactions — important if you take medications for AUD or co-occurring conditions
- Dosing Fundamentals — the "start low, go slow" approach
- Cannabis for Anxiety — relevant for the anxiety component of AUD and recovery
- Cannabis for Insomnia & Sleep — sleep disruption is common in early sobriety
External Resources
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) — comprehensive AUD information and research
- SAMHSA — Substance Abuse and Mental Health Services Administration
- findtreatment.gov — SAMHSA treatment facility locator
- American Society of Addiction Medicine — find an addiction medicine specialist
- SMART Recovery — science-based mutual support for addiction recovery
- National Harm Reduction Coalition — harm reduction principles and resources